Cargando…
ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680178/ https://www.ncbi.nlm.nih.gov/pubmed/26363040 http://dx.doi.org/10.1136/eb-2015-102069 |
| _version_ | 1782405646602207232 |
|---|---|
| author | Nordenskjöld, Axel |
| author_facet | Nordenskjöld, Axel |
| author_sort | Nordenskjöld, Axel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4680178 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46801782015-12-18 ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression Nordenskjöld, Axel Evid Based Ment Health Causes and Risk Factors BMJ Publishing Group 2015-11 2015-09-11 /pmc/articles/PMC4680178/ /pubmed/26363040 http://dx.doi.org/10.1136/eb-2015-102069 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| spellingShingle | Causes and Risk Factors Nordenskjöld, Axel ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression |
| title | ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression |
| title_full | ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression |
| title_fullStr | ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression |
| title_full_unstemmed | ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression |
| title_short | ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression |
| title_sort | ect is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression |
| topic | Causes and Risk Factors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680178/ https://www.ncbi.nlm.nih.gov/pubmed/26363040 http://dx.doi.org/10.1136/eb-2015-102069 |
| work_keys_str_mv | AT nordenskjoldaxel ectissuperiortopharmacotherapyfortheshorttermtreatmentofmedicationresistantinpatientswithbipolardepression |